B Cell Deficient Mice Are Protected from Biliary Obstruction in the Rotavirus-Induced Mouse Model of Biliary Atresia

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Feldman, Amy G ^a   Tucker, Rebecca M ^b   Fenner, Erika K ^b   Pelanda, Roberta ^c   Mack, Cara L ^a,b  

^a CHILDREN S HOSPITAL COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c DEPARTMENT OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE ACTIVATION; BILE DUCT ATRESIA; CD4+ T LYMPHOCYTE; CHOLESTASIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE FREE SURVIVAL; FEMALE; HEPATITIS; HYPERBILIRUBINEMIA; LYMPHOCYTE DEPLETION; MOUSE; NONHUMAN; REGULATORY T LYMPHOCYTE; ROTAVIRUS; ROTAVIRUS INFECTION; SIMIAN ROTAVIRUS; SURVIVAL RATE; TH1 CELL; WILD TYPE;

ANIMALS; ANTIGEN-PRESENTING CELLS; B-LYMPHOCYTES; BILIARY ATRESIA; CHOLESTASIS; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; MICE; ROTAVIRUS; T-LYMPHOCYTES, REGULATORY;

EID: 84882586277     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073644     Document Type: Article

References (60)

1. Mack CL, Feldman AG, Sokol RJ, (2012). Clues to the etiology of bile duct injury in biliary atresia. Semin Liver Dis. 32(4):: 307-16.
2. Mack CL, (2007) The pathogenesis of biliary atresia: evidence for a virus-induced autoimmune disease. Semin Liver Dis 27: 233-242. doi:10.1055/s-2007-985068. PubMed: 17682970.
3. Sokol RJ, Shepherd RW, Superina R, Bezerra JA, Robuck P, et al. (2007) Screening and outcomes in biliary atresia: summary of a National Institutes of Health workshop. Hepatology 46: 566-581. doi:10.1002/hep.21790. PubMed: 17661405.
4. Lykavieris P, Chardot C, Sokhn M, Gauthier F, Valayer J, et al. (2005) Outcome in adulthood of biliary atresia: a study of 63 patients who survived for over 20 years with their native liver. Hepatology 41: 366-371. doi:10.1002/hep.20547. PubMed: 15660386.
5. Sokol RJ, Mack C, Narkewicz MR, Karrer FM, (2003) Pathogenesis and outcome of biliary atresia: current concepts. J Pediatr Gastroenterol Nutr 37: 4-21. doi:10.1097/00005176-200307000-00003. PubMed: 12827000.
6. Riepenhoff-Talty M, Gouvea V, Evans MJ, Svensson L, Hoffenberg E, et al. (1996) Detection of group C rotavirus in infants with extrahepatic biliary atresia. J Infect Dis 174: 8-15. doi:10.1093/infdis/174.1.8. PubMed: 8656017.
7. Tyler KL, Sokol RJ, Oberhaus SM, Le M, Karrer FM, et al. (1998) Detection of reovirus RNA in hepatobiliary tissues from patients with extrahepatic biliary atresia and choledochal cysts. Hepatology 27: 1475-1482. doi:10.1002/hep.510270603. PubMed: 9620316.
8. Jevon GP, Dimmick JE, (1999) Biliary atresia and cytomegalovirus infection: a DNA study. Pediatr Dev Pathol 2: 11-14. doi:10.1007/s100249900083. PubMed: 9841700.
9. Schreiber RA, Kleinman RE, (1993) Genetics, immunology, and biliary atresia: an opening or a diversion? J Pediatr Gastroenterol Nutr 16: 111-113. doi:10.1097/00005176-199302000-00001. PubMed: 8450373.
10. Tan CE, Driver M, Howard ER, Moscoso GJ, (1994) Extrahepatic biliary atresia: a first-trimester event? Clues from light microscopy and immunohistochemistry. J Pediatr Surg 29: 808-814. doi:10.1016/0022-3468(94)90377-8. PubMed: 7521396.
11. Riepenhoff-Talty M, Schaekel K, Clark HF, Mueller W, Uhnoo I, et al. (1993) Group A rotaviruses produce extrahepatic biliary obstruction in orally inoculated newborn mice. Pediatr Res 33: 394-399. doi:10.1203/00006450-199333040-00016. PubMed: 8386833.
12. Petersen C, Grasshoff S, Luciano L, (1998) Diverse morphology of biliary atresia in an animal model. J Hepatol 28: 603-607. doi:10.1016/S0168-8278(98)80283-3. PubMed: 9566828.
13. Mack CL, Tucker RM, Sokol RJ, Kotzin BL, (2005) Armed CD4+ Th1 effector cells and activated macrophages participate in bile duct injury in murine biliary atresia. Clin Immunol 115: 200-209. doi:10.1016/j.clim.2005.01.012. PubMed: 15885644.
14. Shivakumar P, Campbell KM, Sabla GE, Miethke A, Tiao G, et al. (2004) Obstruction of extrahepatic bile ducts by lymphocytes is regulated by IFN-gamma in experimental biliary atresia. J Clin Invest 114: 322-329. doi:10.1172/JCI200421153. PubMed: 15286798.
15. Mack CL, Tucker RM, Lu BR, Sokol RJ, Fontenot AP, et al. (2006) Cellular and humoral autoimmunity directed at bile duct epithelia in murine biliary atresia. Hepatology 44: 1231-1239. doi:10.1002/hep.21366. PubMed: 17058262.
16. Shivakumar P, Sabla G, Mohanty S, McNeal M, Ward R, et al. (2007) Effector role of neonatal hepatic CD8+ lymphocytes in epithelial injury and autoimmunity in experimental biliary atresia. Gastroenterology 133: 268-277. doi:10.1053/j.gastro.2007.04.031. PubMed: 17631148.
17. Yu S, Maiti PK, Dyson M, Jain R, Braley-Mullen H, (2006) B cell-deficient NOD.H-2h4 mice have CD4+CD25+ T regulatory cells that inhibit the development of spontaneous autoimmune thyroiditis. J Exp Med 203: 349-358. doi:10.1084/jem.20051438. PubMed: 16446379.
18. Chan O, Shlomchik MJ, (1998) A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr/lpr mice. J Immunol 160: 51-59. PubMed: 9551955.
19. O'Neill SK, Shlomchik MJ, Glant TT, Cao Y, Doodes PD, et al. (2005) Antigen-specific B cells are required as APCs and autoantibody-producing cells for induction of severe autoimmune arthritis. J Immunol 174: 3781-3788. PubMed: 15749919.
20. Serreze DV, Fleming SA, Chapman HD, Richard SD, Leiter EH, et al. (1998) B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. J Immunol 161: 3912-3918. PubMed: 9780157.
21. Levesque MC, St Clair EW, (2008) B cell-directed therapies for autoimmune disease and correlates of disease response and relapse. J Allergy Clin Immunol 121: 13-21; quiz 22-13 doi:10.1016/j.jaci.2007.12.053. PubMed: 18206502.
22. Hadchouel M, Hugon RN, Odievre M, (1981) Immunoglobulin deposits in the biliary remnants of extrahepatic biliary atresia: a study by immunoperoxidase staining in 128 infants. Histopathology 5: 217-221. doi:10.1111/j.1365-2559.1981.tb01779.x. PubMed: 7216182.
23. Lu BR, Brindley SM, Tucker RM, Lambert CL, Mack CL, (2010) Alpha-enolase autoantibodies cross-reactive to viral proteins in a mouse model of biliary atresia. Gastroenterology 139: 1753-1761. doi:10.1053/j.gastro.2010.07.042. PubMed: 20659472.
24. Vermeulen N, de Béeck KO, Vermeire S, Van Steen K, Michiels G, et al. (2011) Identification of a novel autoantigen in inflammatory bowel disease by protein microarray. Inflamm Bowel Dis 17: 1291-1300. doi:10.1002/ibd.21508. PubMed: 21560193.
25. Pelanda R, Braun U, Hobeika E, Nussenzweig MC, Reth M, (2002) B cell progenitors are arrested in maturation but have intact VDJ recombination in the absence of Ig-alpha and Ig-beta. J Immunol 169: 865-872. PubMed: 12097390.
26. Minegishi Y, Coustan-Smith E, Rapalus L, Ersoy F, Campana D, et al. (1999) Mutations in Igalpha (CD79a) result in a complete block in B-cell development. J Clin Invest 104: 1115-1121. doi:10.1172/JCI7696. PubMed: 10525050.
27. Gong S, Nussenzweig MC, (1996) Regulation of an early developmental checkpoint in the B cell pathway by Ig beta. Science 272: 411-414. doi:10.1126/science.272.5260.411. PubMed: 8602530.
28. Barnes BH, Tucker RM, Wehrmann F, Mack DG, Ueno Y, et al. (2009) Cholangiocytes as immune modulators in rotavirus-induced murine biliary atresia. Liver Int 29: 1253-1261. doi:10.1111/j.1478-3231.2008.01921.x. PubMed: 19040538.
29. Stasi R, Cooper N, Del Poeta G, Stipa E, Laura Evangelista M, et al. (2008) Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab. Blood 112: 1147-1150. doi:10.1182/blood-2007-12-129262. PubMed: 18375792.
30. Hamel KM, Cao Y, Ashaye S, Wang Y, Dunn R, et al. (2011) B cell depletion enhances T regulatory cell activity essential in the suppression of arthritis. J Immunol 187: 4900-4906. doi:10.4049/jimmunol.1101844. PubMed: 21948985.
31. Sfikakis PP, Souliotis VL, Fragiadaki KG, Moutsopoulos HM, Boletis JN, et al. (2007) Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis. Clin Immunol 123: 66-73. doi:10.1016/j.clim.2007.03.366. PubMed: 17275413.
32. Myers RC, King RG, Carter RH, Justement LB, (2013) Lymphotoxin alpha(1) beta(2) expression on B cells is required for follicular dendritic cell activation during the germinal center response. Eur J Immunol 43: 348-359. doi:10.1002/eji.201242471. PubMed: 23112125.
33. Saxena V, Shivakumar P, Sabla G, Mourya R, Chougnet C, et al. (2011) Dendritic cells regulate natural killer cell activation and epithelial injury in experimental biliary atresia. Sci Transl Med 3: 102ra194. PubMed: 21957172.
34. Chan OT, Madaio MP, Shlomchik MJ, (1999) B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity. J Immunol 163: 3592-3596. PubMed: 10490951.
35. Braley-Mullen H, Yu S, (2000) Early requirement for B cells for development of spontaneous autoimmune thyroiditis in NOD.H-2h4 mice. J Immunol 165: 7262-7269. PubMed: 11120860.
36. Chan OT, Hannum LG, Haberman AM, Madaio MP, Shlomchik MJ, (1999) A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med 189: 1639-1648. doi:10.1084/jem.189.10.1639. PubMed: 10330443.
37. Rodríguez-Pinto D, (2005) B cells as antigen presenting cells. Cell Immunol 238: 67-75. doi:10.1016/j.cellimm.2006.02.005. PubMed: 16574086.
38. Chan OT, Hannum LG, Haberman AM, Madaio MP, Shlomchik MJ, (1999) A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med 189: 1639-1648. doi:10.1084/jem.189.10.1639. PubMed: 10330443.
39. Falcone M, Lee J, Patstone G, Yeung B, Sarvetnick N, (1998) B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice. J Immunol 161: 1163-1168. PubMed: 9686575.
40. Noorchashm H, Lieu YK, Noorchashm N, Rostami SY, Greeley SA, et al. (1999) I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice. J Immunol 163: 743-750. PubMed: 10395666.
41. Lyons JA, San M, Happ MP, Cross AH, (1999) B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide. Eur J Immunol 29: 3432-3439. doi:10.1002/(SICI)1521-4141(199911)29:11. PubMed: 10556797.
42. Ron Y, Sprent J, (1987) T cell priming in vivo: a major role for B cells in presenting antigen to T cells in lymph nodes. J Immunol 138: 2848-2856. PubMed: 2952725.
43. Kurt-Jones EA, Liano D, HayGlass KA, Benacerraf B, Sy MS,et al (1988) The role of antigen-presenting B cells in T cell priming in vivo. Studies of B cell-deficient mice. J Immunol 140: 3773-3778. PubMed: 2453554.
44. Barr TA, Brown S, Mastroeni P, Gray D,. (2010) TLR and B cell receptor signals to B cells differentially program primary and memory Th1 responses to Salmonella enterica. J Immunol 185: 2783-2789. doi:10.4049/jimmunol.1001431. PubMed: 20675594.
45. Mastroeni P, Simmons C, Fowler R, Hormaeche CE, Dougan G, (2000) Igh-6(-/-) (B-cell-deficient) mice fail to mount solid acquired resistance to oral challenge with virulent Salmonella enterica serovar typhimurium and show impaired Th1 T-cell responses to Salmonella antigens. Infect Immun 68: 46-53. doi:10.1128/IAI.68.1.46-53.2000. PubMed: 10603367.
46. Linton PJ, Bautista B, Biederman E, Bradley ES, Harbertson J, et al. (2003) Costimulation via OX40L expressed by B cells is sufficient to determine the extent of primary CD4 cell expansion and Th2 cytokine secretion in vivo. J Exp Med 197: 875-883. doi:10.1084/jem.20021290. PubMed: 12668647.
47. Linton PJ, Harbertson J, Bradley LM, (2000) A critical role for B cells in the development of memory CD4 cells. J Immunol 165: 5558-5565. PubMed: 11067910.
48. Rodríguez-Pinto D, Moreno J, (2005) B cells can prime naive CD4+ T cells in vivo in the absence of other professional antigen-presenting cells in a CD154-CD40-dependent manner. Eur J Immunol 35: 1097-1105. doi:10.1002/eji.200425732. PubMed: 15756646.
49. Sfikakis PP, Boletis JN, Lionaki S, Vigklis V, Fragiadaki KG, et al. (2005) Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand: an open-label trial. Arthritis Rheum 52: 501-513. doi:10.1002/art.20858. PubMed: 15693003.
50. Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA, (2004) Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 199: 971-979. doi:10.1084/jem.20031579. PubMed: 15067033.
51. Lawson CA, Brown AK, Bejarano V, Douglas SH, Burgoyne CH, et al. (2006) Early rheumatoid arthritis is associated with a deficit in the CD4+CD25high regulatory T cell population in peripheral blood. Rheumatology (Oxf) 45: 1210-1217. doi:10.1093/rheumatology/kel089. PubMed: 16571607.
52. Lindley S, Dayan CM, Bishop A, Roep BO, Peakman M, et al. (2005) Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. Diabetes 54: 92-99. doi:10.2337/diabetes.54.1.92. PubMed: 15616015.
53. Miethke AG, Saxena V, Shivakumar P, Sabla GE, Simmons J, et al. (2010) Post-natal paucity of regulatory T cells and control of NK cell activation in experimental biliary atresia. J Hepatol 52(5):718-26.
54. Tucker RM, Feldman AG, Fenner EK, Mack CL, (2013) Regulatory T cells inhibit Th1 cell-mediated bile duct injury in murine biliary atresia. J Hepatol [Epub ahead of print].
55. Brindley SM, Lanham AM, Karrer FM, Tucker RM, Fontenot AP, Mack CL, (2012). Cytomegalovirus-specific T-cell reactivity in biliary atresia at the time of diagnosis is associated with deficits in regulatory T cells. Hepatology. 55(4):1130-8.
56. Olson TS, Bamias G, Naganuma M, Rivera-Nieves J, Burcin TL, et al. (2004) Expanded B cell population blocks regulatory T cells and exacerbates ileitis in a murine model of Crohn disease. J Clin Invest 114: 389-398. doi:10.1172/JCI200420855. PubMed: 15286805.
57. Cohen SB, Emery P, Greenwald MW, Dougados M, Furie RA, et al. (2006) Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. Arthritis Rheum 54: 2793-2806. doi:10.1002/art.22025. PubMed: 16947627.
58. Hauser SL, Waubant E, Arnold DL, Vollmer T, Antel J, et al. (2008) B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med 358: 676-688. doi:10.1056/NEJMoa0706383. PubMed: 18272891.
59. Bar-Or A, Calabresi PA, Arnold D, Markowitz C, Shafer S, et al. (2008) Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial. Ann Neurol 63: 395-400. doi:10.1002/ana.21363. PubMed: 18383069.
60. Pescovitz MD, Greenbaum CJ, Krause-Steinrauf H, Becker DJ, Gitelman SE, et al. (2009) Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. N Engl J Med 361: 2143-2152. doi:10.1056/NEJMoa0904452. PubMed: 19940299.